We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.66%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$59.3B
AUM Growth
+$5.36B
Cap. Flow
+$49.9M
Cap. Flow %
0.08%
Top 10 Hldgs %
30.78%
Holding
972
New
135
Increased
326
Reduced
323
Closed
129

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$111M
2
AMZN icon
Amazon
AMZN
+$108M
3
COF icon
Capital One
COF
+$106M
4
JCI icon
Johnson Controls International
JCI
+$99.8M
5
NEE icon
NextEra Energy
NEE
+$98M

Sector Composition

Rank Sector Weight
1 Technology 29.16%
2 Healthcare 13.82%
3 Financials 12.25%
4 Consumer Discretionary 9.51%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MELI icon
751
Mercado Libre
MELI
$95.7B
$2.61M ﹤0.01%
+1,000
New +$2.34M
FBIN icon
752
Fortune Brands Innovations
FBIN
$6.29B
$2.6M ﹤0.01%
50,500
-260,000
-84% -$13.6M
DOW icon
753
Dow Inc
DOW
$21.9B
$2.58M ﹤0.01%
97,400
-245,000
-72% -$7.13M
WFRD icon
754
Weatherford International
WFRD
$6.41B
$2.52M ﹤0.01%
+50,000
New +$2.32M
AARD
755
Aardvark Therapeutics
AARD
$158M
$2.37M ﹤0.01%
175,000
-75,000
-30% -$773K
CHE icon
756
Chemed
CHE
$7.05B
$2.19M ﹤0.01%
+4,500
New +$2.56M
TRML
757
DELISTED
Tourmaline Bio
TRML
$2.17M ﹤0.01%
135,637
-364,363
-73% -$5.9M
AIV
758
Aimco
AIV
$384M
$2.16M ﹤0.01%
+250,000
New +$2.02M
AVY icon
759
Avery Dennison
AVY
$13.3B
$2.04M ﹤0.01%
11,600
-140,536
-92% -$24.6M
FLOC
760
Flowco Holdings
FLOC
$852M
$1.98M ﹤0.01%
111,199
-147,224
-57% -$2.81M
ELVN icon
761
Enliven Therapeutics
ELVN
$4.37B
$1.93M ﹤0.01%
96,000
-354,000
-79% -$6.7M
SANA icon
762
Sana Biotechnology
SANA
$946M
$1.92M ﹤0.01%
+702,000
New +$1.45M
SSTK icon
763
Shutterstock
SSTK
$221M
$1.9M ﹤0.01%
100,000
AII
764
American Integrity Insurance
AII
$410M
$1.88M ﹤0.01%
+102,342
New +$1.73M
ROL icon
765
Rollins
ROL
$18.2B
$1.83M ﹤0.01%
32,450
-3,900
-11% -$219K
KPTI icon
766
Karyopharm Therapeutics
KPTI
$44.4M
$1.82M ﹤0.01%
421,322
CRCL
767
Circle Internet Group
CRCL
$15.7B
$1.81M ﹤0.01%
+10,000
New +$1.63M
CPB icon
768
Campbell Soup
CPB
$6.79B
$1.75M ﹤0.01%
57,246
-122,300
-68% -$4.3M
NVS icon
769
Novartis
NVS
$291B
$1.75M ﹤0.01%
+14,481
New +$1.63M
PLGO
770
Pelagos Insurance Capital
PLGO
$2.14B
$1.69M ﹤0.01%
+101,764
New +$1.69M
KVYO icon
771
Klaviyo
KVYO
$5.72B
$1.68M ﹤0.01%
50,000
-25,000
-33% -$792K
XIFR
772
XPLR Infrastructure LP
XIFR
$1.11B
$1.64M ﹤0.01%
+200,000
New +$1.74M
CBIO
773
Crescent Biopharma
CBIO
$608M
$1.63M ﹤0.01%
100,912
+50,000
+98% +$1.06M
ACGL icon
774
Arch Capital
ACGL
$33.9B
$1.53M ﹤0.01%
16,800
-400,300
-96% -$36.9M
XLF icon
775
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
$1.52M ﹤0.01%
+29,000
New +$1.44M

Similar funds

Adage Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Adage Capital Partners held 972 positions worth $59.3B, up 9.9% from $54B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Adage Capital Partners's Q2 2025 filing shows 135 new, 326 increased, 323 reduced and 129 closed positions. Its largest new stake was Capital One: 565,828 shares worth $120M. The largest sale was Discover Financial Services, an estimated $163M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q2 2025 buy was Capital One: 565,828 shares worth $120M.
  • Adage Capital Partners added most to CSX Corp in Q2 2025, an estimated $111M increase.
  • Adage Capital Partners's biggest Q2 2025 reduction was 3M, cutting an estimated $159M.
  • Adage Capital Partners fully exited Discover Financial Services in Q2 2025, selling an estimated $163M.
  • Adage Capital Partners's ten largest holdings make up 31% of its $59.3B portfolio in Q2 2025.
  • Adage Capital Partners opened 135 new positions and closed 129 in Q2 2025.
  • Adage Capital Partners's portfolio value rose 9.9% quarter-over-quarter to $59.3B.

Based on Adage Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.